News / Africa

Treating HIV Positive Women

Samples of Nevirapine, an antiretroviral AIDS drug used since the 1990s, are displayed at the National Institutes of Health in Memphis, Tenn.  (AP Photo/APTN)Samples of Nevirapine, an antiretroviral AIDS drug used since the 1990s, are displayed at the National Institutes of Health in Memphis, Tenn. (AP Photo/APTN)
x
Samples of Nevirapine, an antiretroviral AIDS drug used since the 1990s, are displayed at the National Institutes of Health in Memphis, Tenn.  (AP Photo/APTN)
Samples of Nevirapine, an antiretroviral AIDS drug used since the 1990s, are displayed at the National Institutes of Health in Memphis, Tenn. (AP Photo/APTN)
Joe DeCapua
New research shows that a combination of inexpensive antiretroviral drugs can be very effective in treating HIV positive women in developing countries. In fact, new research shows the treatment is just as effective as a much more expensive drug combination. However, the study also shows the cheaper drugs can carry a greater risk side effects.

Antiretroviral drug treatment has proven effective in suppressing the AIDS virus and saving lives. The drugs have changed the prognosis of the disease from one of certain death – usually within 10 years – to a chronic illness.

In 2010, the World Health Organization recommended that treatment of HIV infected women in poor areas should include the drug navirapine. It’s inexpensive and is often used in preventing the transmission of HIV from mothers to their newborns.

Research at Brigham and Women’s Hospital in Boston shows navirapine, in combination with other antiretrovirals, is just as effective as another combination that costs a lot more. Dr. Shahin Lockman led a study of 500 HIV infected African women who were in advanced stages of HIV/AIDS.

“There is very little known about the optimal regimen to use in persons living with HIV in resource-limited settings and in particular women living with HIV globally. The burden of HIV disease really is in resource-limited settings,” she said.

Resistance

Lockman is an associate professor of medicine at Harvard Medical School. She said the study of the navirapine-based combination looked at possible drug resistance. It’s known that when navirapine is given to women by itself – not part of a combination – resistance can develop.

“Many women are diagnosed with HIV and first enter the HIV care system when pregnant. And they are then offered often just one or two antiretroviral drugs to try and interrupt transmission of HIV to their baby. But these drugs, in particular single dose navirapine, which a woman takes during labor and gives one dose to her baby, while somewhat effective in reducing transmission to the baby, leaves three-quarters of the women with detectable drug resistant virus,’ she said.

The question is did that same drug resistance to navirapine occur when combined with several other antiretrovirals? The answer is no. But there was other good news, as well.

“In the women who had not previously taken single dose navirapine about 83 percent of women were able to suppress their virus and stay alive and well after starting the navirapine based regimen. So comparing that to the best first line regimens that we have here in the U.S., where the success rate is closer to 90 to 95 percent, 83 percent is not perfect, but it’s solidly good,” said Lockman.

However, while it was not as good as regimens here in the U.S., it was as good as a much more expensive regimen that is available in some developing countries. The downside of the navirapine combination, however, is the side effects.

“A reasonable number of patients had to switch off of navirapine treatment because of toxicity. And that was not particularly surprising. So about 14 percent of the women had to stop navirapine because of toxicity,” she said.

Navirapine can be toxic to the liver and skin. Lockman said if treatment is not stopped soon enough after symptoms appear, women can develop a “life-threatening drug sensitivity reaction.” Women in the study were closely monitored, though, and given a different drug regimen if necessary. But women not in such a study and not closely monitored could be at risk. Some may simply stop taking the drugs and forego treatment. And without treatment, Lockman said, they will die. She added that women deserve better.

“We really do need to push to get safer, better tolerated more effective treatment accessible so that even if you only have one or perhaps two lines of treatment the majority of people who start these can stay on them for life without toxicity,” she said.

She estimated millions of women need such treatment. She said PEPFAR - the President’s Emergency Plan for AIDS Relief - and the Clinton Global Initiative are some of best efforts to achieve that goal. 

The study was funded in part by the National Institute of Allergy and Infectious Diseases and the National Center for Research.

You May Like

China May Be Biggest Winner From Ukraine Crisis

Missile sales, oil and gas shipments are among many areas that may drive Beijing and Moscow closer together in coming years More

Obama Faces Chaotic World, Limits of Power

Current foreign policy issues bring into focus challenges for US policymakers who are mindful of Americans' waning appetite for overseas military engagements More

SADC Meeting Lesotho Officials to Resolve Stalemate

Official says regional bloc has been engaged with leaders in Lesotho to resolve political disagreement that led to coup attempt More

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
West Africa Ebola Vaccine Trials Possible by Early 2015i
X
Carol Pearson
August 30, 2014 7:14 PM
A U.S. health agency is speeding up clinical trials of a possible vaccine against the deadly Ebola virus that so far has killed more than 1,500 people in West Africa. If successful, the next step would be a larger trial in countries where the outbreak is occurring. VOA's Carol Pearson has more.
Video

Video West Africa Ebola Vaccine Trials Possible by Early 2015

A U.S. health agency is speeding up clinical trials of a possible vaccine against the deadly Ebola virus that so far has killed more than 1,500 people in West Africa. If successful, the next step would be a larger trial in countries where the outbreak is occurring. VOA's Carol Pearson has more.
Video

Video Survivors Commemorate 70th Anniversary of Nazi Liquidation of Jewish Ghetto

When the German Nazi army occupied the Polish city of Lodz in 1939, it marked the beginning of a long nightmare for the Jewish community that once made up one third of the population. Roughly 200,000 people were forced into the Lodz Ghetto. Less than 7,000 survived. As VOA’s Kane Farabaugh reports, some survivors gathered at the Union League Club in Chicago on the 70th anniversary of the liquidation of the Lodz Ghetto to remember those who suffered at the hands of the Nazi regime.
Video

Video Cost to Raise Child in US Continues to Rise

The cost of raising a child in the United States continues to rise. In its latest annual report, the U.S. Department of Agriculture says middle income families with a child born in 2013 can expect to spend more than $240,000 before that child turns 18. And sending that child to college more than doubles that amount. VOA’s Deborah Block visited with a couple with one child in Alexandria, Virginia, to learn if the report reflects their lifestyle.
Video

Video Chaotic Afghan Vote Recount Threatens Nation’s Future

Afghanistan’s troubled presidential election continues to be rocked by turmoil as an audit of the ballots drags on. The U.N. says the recount will not be completed before September 10. Observers say repeated disputes and delays are threatening the orderly transfer of power and could have dangerous consequences. VOA correspondent Meredith Buel reports.
Video

Video Ukraine Battles Pro-Russia Rebel Assault

After NATO concluded an emergency meeting to discuss the crisis in eastern Ukraine, the country is struggling to contain heavy fighting near the strategic port of Mariupol, on the Azov Sea. Separatist rebels are trying to capture the city, allegedly with Russian military help, and Ukraine's defense forces are digging in. VOA's Daniel Schearf spoke with analysts about what lies ahead for Ukraine.
Video

Video Growing Business Offers Paint with a Twist of Wine

Two New Orleans area women started a small business seven years ago with one thing in mind: to help their neighbors relieve the stress of coping with a hurricane's aftermath. Today their business, which pairs painting and a little bit of wine, has become one of the fastest growing franchises across the U.S. VOA’s June Soh met the entrepreneurs at their newest franchise location in the Washington suburbs.
Video

Video Ebola Vaccine Trials To Begin Next Week

The National Institutes of Health says it is launching early stage trials of a vaccine to prevent the Ebola virus, which has infected or killed thousands of people across West Africa. The World Health Organization says Ebola could infect more than 20,000 people across the region by the time the outbreak is over. The epidemic has health experts and governments scrambling to prevent more people from becoming infected. Zlatica Hoke has more.
Video

Video Asian Bacteria Threatens Florida Orange Trees

Florida's citrus fruit industry is facing a serious threat from a bacteria carried by the Asian insect called psyllid. The widespread infestation again highlights the danger of transferring non-native species to American soil. VOA’s George Putic reports.
Video

Video Aging Will Reduce Economic Growth Worldwide in Coming Decades

The world is getting older, fast. And as more people retire each year, fewer working-age people will be there to replace them. Bond rating agency Moody’s says that will lead to a decline in household savings; reducing global investments - which in turn, will lead to slower economic growth around the world. But experts say it’s not too late to mitigate the economic impact of the world’s aging populations. Mil Arcega has more.
Video

Video Is West Doing Enough to Tackle Islamic State?

U.S. President Barack Obama has ruled out sending ground troops to Iraq to fight militants of the so-called Islamic State, or ISIS, despite officials in Washington describing the extremist group as the biggest threat the United States has faced in years. Henry Ridgwell reports from London on the growing uncertainty over whether the West’s response to ISIS will be enough to defeat the terrorist threat.
Video

Video Coalition to Fight Islamic State Could Reward Assad

The United States along with European and Mideast allies are considering a broader assault against Islamic State fighters who have spread from Syria into Iraq and risk further destabilizing an already troubled region. But as VOA State Department Correspondent Scott Stearns reports, confronting those militants could end up helping the embattled Syrian President Bashar al-Assad.
Video

Video Made in America Socks Get Toehold in Online Fashion Market

Three young entrepreneurs are hoping to revolutionize the high-end sock industry by introducing all-American creations of their own. And they’re doing most of it the old-fashioned way. VOA’s Julie Taboh recently caught up with them to learn what goes into making their one-of-a-kind socks.
Video

Video Americans, Ex-Pats Send Relief Supplies to West Africa

Health organizations from around the world are sending supplies and specialists to the West African countries that are dealing with the worst Ebola outbreak in history. On a smaller scale, ordinary Americans and African expatriates living in the United States are doing the same. VOA's Carol Pearson reports.

AppleAndroid